Skip to main content

Table 1 Association of WWP2 levels with clinical and pathological features of GC patients

From: WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein

Variables

N

Tumor WWP2 expression

P value

WWP2High (%)

WWP2Low (%)

Age (years)

  < 65

66

38(57.6)

28(42.4)

0.567

  ≥ 65

64

40(62.5)

24(37.5)

Gender

  Male

75

43(57.3)

32(42.7)

0.469

  Female

55

35(63.6)

20(36.4)

Tumor size (cm)

  < 5

51

28(54.9)

23(45.1)

0.340

  ≥ 5

79

50(63.3)

29(36.7)

Differentiation

  Well or Moderately

68

37(54.4)

31(45.6)

0.173

  Poor

62

41(66.1)

21(33.9)

TNM stage

  I-II

57

27(47.4)

30(52.6)

0.009

  III-IV

73

51(69.9)

22(30.1)

Depth of invasion

  T1-T2

54

25(46.3)

29(53.7)

0.007

  T3-T4

76

53(69.7)

23(30.3)

Tumor location

  Proximal

59

34(57.6)

25(42.4)

0.615

  Distal

71

44(62.0)

27(38.0)

Lauren classification

  Intestinal type

65

35(53.8)

30(46.2)

0.152

  Diffuse type

65

43(66.2)

22(33.8)

Lymph node metastasis

  N0

60

30(50.0)

30(50.0)

0.031

  Nx

70

48(68.6)

22(31.4)

  1. P-values determined using χ2 test
  2. Bold: P ≤ 0.05 were regarded as statistically significant